The UBC Faculty of Medicine’s Djavad Mowafaghian Centre for Brain Health (DMCBH) is leading a strategic effort to increase our understanding of the brain and neurological and mental health diseases.
This strategy that addresses these diseases in novel ways, by building upon existing strengths, and by partnering with new leadership and initiatives that are expanding research efforts to translate that knowledge into new treatments for patient care. Ultimately, it will be through knowledge creation, translation and exchange, where that we gain insights into brain heath and promote improved outcomes in patient and public health.
The neuroscience community at UBC has extensive research pre-eminence; however, to excel further in this area of prominence, the funding for the UBC Excellence Chair in Brain Health will enable the Faculty, and the University to deepen and extend our contributions to shaping our health system and being socially accountable to our society.
The Centre for Brain Health aims to build upon the strengths in our research environment by integrating the most promising areas of fundamental and early translational research at UBC, including advances in research in the following complementary areas: neuroinflammation, synaptic function and brain circuitry, and the linkages with brain imaging.
These are all key areas of research that will create transformational impact by advancing our understanding of the brain in health and disease, and for suggesting novel targets and biomarkers for clinical trials. Insights for into rational therapies for treating neurodegeneration and other disease of the brain including mental health is are likely to come from transformational research in these complementary areas.
The Chair is open to an outstanding individual within the neurosciences research community who brings a fresh dimension to the study of brain health coupled with the capability of providing leadership and direction within the DMCBH.
The ultimate goal of this research cluster is to translate these novel approaches into the clinic in the form of new therapies, the identification of novel biomarkers to test the effects of such therapies, and to identify populations at increased risk of future neurological and psychiatric disease, as well as to bridge links and rapidly mobilize through collaborations between basic biomedical and clinical research programs.
Collectively, this goal will have a significant impact by providing a better quality of life for patients through targeted therapies and early detection, and ultimately contributing to decreased healthcare costs due to effective management of brain illnesses.
To apply, please view the full position recruitment advertisement below:
For additional information please contact: